Member Info for itsallamess

Webb, dan.. fully agree. If we can go it alone with the recent developments on Traumakine so much the better.

Thus is the deal:
1. Traumakine in who and remap trials. These are doing the job for us, testing our drug out on patients
2. Fast track a real likelihood
3. Todays RNS with cash now placed for us to make loads more of Traumakine for commercial purposes.

We dont need a partner reaping a chunk of the profits... unless they can bring g value to the table. But at this point not sure what any partner can provide that we are not doing ourselves

Mary moo, I droped them a email reminding then to send the details of how I can join this morning.

Maybe get a reply with instructions in the morning

Thank you finland bussiness for a really cheap loan to pay for Traumakine. 3 years before we have to pay any of it back. By then we will be a major pharma producing Traumakine plus the SP will be on another level with clevegen

Coming back to this:
"The Loan funds will be used to develop and select a new cell line that can be used for future commercial scale production of Faron's human IFN beta-1a"

So we know we are in a dispute with the old manurfacture, so the solution.?
"initiate a new state of the art process for the manufacturing of interferon (IFN) beta-1a"

If you look online it's hard to see if anyone apart from a couple of companies manufacture interferon beta 1a!

What's the new process?
Maybe its Traumakine in powderform (trademarked)

This is massive news... official results published on interferon beta 1a on WHO and Remap trials and we are in business

Anyone remember what the last 3 job oppotunities where with faron.

One was packaging and sellin think
Another was lab work?
Just trying to see if there is a concection to the RNS this morning?

Has anyone recieved any new info from them as to how to access the webcast?

"Thank you for registering your interest in Faron's R&D day. I can confirm that you've been added to the list of attendees
Details on how to access the webcast will be shared nearer to the date"

"The Loan funds will be used to develop and select a new cell line that can be used for future commercial scale production of Faron's human IFN beta-1a"

Once who and remap start giving results.. once interferon beta 1a IV form becomes a recommended treatment, it then becomes a drug that needs to be paid for.

Yes we gave a bunch of treatments for the trial as a freebie but the end game is being set up for commercial scale product!

Dr. Markku Jalkanen, Faron's CEO, said: "This is a very important initiative backed by the Finnish Government. We have a good existing stock of IFN beta-1a, but given the on-going clinical trials (REMAP-CAP and The WHO's Solidarity Trial) and the potential for increasing future demand of IFN beta-1a for COVID-19 and other viral infections like influenza we need to begin up-scaling our manufacturing capacity."

I think marku is pretty clear here. We will need more interferon beta 1a. Remap and solidarity will want more from us.. why? Because it's working. They will be talking to farn and while we wait for official news, the fact that they want more of our drug speaks volumes. (As opposed to the controversy with hydroxychloroquine which seems like it's not working for covid symptoms)

R and d day will be interesting.

https://www.labiotech.eu/tops/biotech-companies-finland/

There are other manurfactures of interferon beta 1a. So by setting ourselves up as a manurfacture of interferon beta 1 a is really clever

1. Because we cut a middle man out
2. We have the control
3. It starting to look like demand for interferon beta 1a is going to be sort after
4. We will have control over supply for Traumakine
5. The issue we have had with the old manurfacture will be a thing of the past
6. finland is investing in finland to be a global leader in pharma
7. We are a top company in finland
8. It's looking like a partner wont be needed
9. On the latest investment update for the company it says farons AIM is to be a global pharmaceuticals company
10. Bring it all on

It all adds to the fact that interferon beta 1a is having a positive effect on covid paitents.

Sp isnt going down, for a few weeks it's been hovering around 330 - 349

Bobbing around in this tight price range.

So unfair comment long to say the SP is going down

If you are a holder then just sell up and no doubt you will be able to sleep better at night

Do we really need a partner for clevegen?

Around 17 million in the bank.
Support shown from the EU
Support by the finish govement grant

After next trials which are fully funded... When the results are seen. Significant share value added. Not sure we will need a partner?

Every RNS is great news for Faron

Added confidence from the EU.. Next step they will approve FastTrack stays!

Long

Traumakine is a drug designed to treat ARDS
ARDS is also a condition that Covid 19 causes

But you already know this?
This is not new information. It's all in the various RNS. But take a look at the RNSs on faron inclusion to the remap cap and who solidarity trials

A year we calculated the free float to be around just 20% ofvyhe shares. Then the Naz floated. They started off with a private placing to nordic investor's, then the second placing justvrecently raising 14 million

I've lost track what the percentage of free float is now.

As a complete wild guess I would say there is a good chance its 50/50 split between Aim and Naz

Oil

I was looking for that myself

One thing is for sure lago has been taking around 20,000 shares off the aim market everyday for months. And then a few big days, I remember a couple of weeks ago 100,000 in one day

1 share trade on the Naz

This is a test, another 5000 trade. should see on the naz sells from lago piping up here soon.

http://www.nasdaqomxnordic.com/aktier/microsite?Instrument=HEX185076&name=Faron%20Pharmaceuticals%20Oy&ISIN=FI4000153309

Just hot a reply
"Thank you for registering your interest in Faron's R&D day. I can confirm that you've been added to the list of attendees
Details on how to access the webcast will be shared nearer to the date"